Hepalink Pharmaceutical Plans IPO With 40.1 Million "A" Shares
This article was originally published in PharmAsia News
Executive Summary
Shenzhen Hepalink Pharmaceutical published a summary prospectus Apr. 19 proposing an IPO of 40.1 million "A" shares